ArticlebioRxiv : the preprint server for biology2026
Modeling Reveals How Direct-Acting Antivirals Redirect HBV Capsid Assembly Pathways to Noninfectious Products.
Layne B Frechette et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.